[Federal Register Volume 76, Number 22 (Wednesday, February 2, 2011)]
[Notices]
[Pages 5814-5815]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-2261]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates (All times are Eastern Time):
8:15 a.m.-3:45 p.m., February 23, 2011.
8:15 a.m.-5:00 p.m., February 24, 2011.
8:15 a.m.-10:30 a.m., February 25, 2011
Public Comment Times and Dates (All times are Eastern Time):
6:30 p.m.-7:30 p.m.*, February 23, 2011.
5:30 p.m.-7 p.m.*, February 24, 2011.
* Please note that the public comment periods may end before the
times indicated, following the last call for comments. Members of the
public who wish to provide public comments should plan to attend public
comment sessions at the start times listed.
Place: Augusta Marriott Hotel and Suites, Two Tenth Street,
Augusta, Georgia 30901; Phone: 800-868-5354; Fax: 404-377-1587. Audio
Conference Call via FTS Conferencing. The USA toll-free dial-in number
is 1-866-659-0537 with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 150 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2011.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters To Be Discussed: The agenda for the Advisory Board meeting
includes: NIOSH Program Update and Program Evaluation Update;
Department of Labor (DOL) Program Update; Department of Energy (DOE)
Program Update; Savannah River Site Work Group Update; NIOSH Savannah
River Site Activities Update; Use of Co-worker Data; the Application of
OTIB-70 for Residual Contamination Periods; SEC petitions for: Linde
Ceramics Plant (Tonawanda, New York), Dow Chemical (Madison, Illinois),
Chapman Valve (Indian Orchard, Massachusetts), Wah Chang (Albany, OR),
Grand Junction Operations Office (Grand Junction, CO), Bliss and
Laughlin Steel (Buffalo, NY), Feed Materials Production Center
(Fernald, OH), Norton Company (Worcester, MA), and Vitro Manufacturing
(Canonsburg, PA); SEC Petition Status Updates; Subcommittee and Work
Group Reports; Board Work Sessions, and an Administrative Session.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted in accordance with the redaction policy provided below. Any
written comments received will be provided at the meeting and should be
submitted to the contact person below well in advance of the meeting.
[[Page 5815]]
Policy on Redaction of Board Meeting Transcripts (Public Comment):
(1) If a person making a comment gives his or her name, no attempt will
be made to redact that name. (2) NIOSH will take reasonable steps to
ensure that individuals making public comment are aware of the fact
that their comments (including their name, if provided) will appear in
a transcript of the meeting posted on a public website. Such reasonable
steps include: (a) A statement read at the start of each public comment
period stating that transcripts will be posted and names of speakers
will not be redacted; (b) A printed copy of the statement mentioned in
(a) above will be displayed on the table where individuals sign up to
make public comments; (c) A statement such as outlined in (a) above
will also appear with the agenda for a Board Meeting when it is posted
on the NIOSH website; (d) A statement such as in (a) above will appear
in the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals personal
information (e.g., medical information) about themselves that
information will not usually be redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator will, however, review such
revelations in accordance with the FOIA and the Federal Advisory
Committee Act and if deemed appropriate, will redact such information.
(4) All disclosures of information concerning third parties will be
redacted. (5) If it comes to the attention of the DFO that an
individual wishes to share information with the Board but objects to
doing so in a public forum, the DFO will work with that individual, in
accordance with the Federal Advisory Committee Act, to find a way that
the Board can hear such comments.
Contact Person for More Information: Theodore Katz, M.P.A.,
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta GA
30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO, e-mail:
[email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Dated: January 26, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-2261 Filed 2-1-11; 8:45 am]
BILLING CODE 4163-18-P